The Essure implant, which is available on the NHS, has left some women in chronic pain, and some have even needed hysterectomies to remove it.
The pharmaceutical company Bayer said the decision to stop sales was being taken for commercial reasons.
The sale of the implants in the EU was temporarily suspended last month.
Bayer has asked hospitals in the UK not to use their existing stocks during this time.
It is a voluntary request and up to individual trusts to decide what to do.
'Felt like a burden'
